Reports Q2 revenue $1.7M vs $2.19M last year. “While we faced a temporary headwind this quarter due to a vendor issue, our response demonstrated the strength of our operational discipline and our commitment to patients,” said John Erb, Chairman of the Board and CEO of Nuwellis (NUWE). “We’re entering the second half of the year with clear priorities, a sharpened focus on our core markets, and the confidence that we’re executing on the right strategy to drive long-term growth.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- NUWE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Nuwellis to exit international operations to accelerate U.S. revenue growth
- Nuwellis postpones Q2 earnings release, conference call
- Nuwellis announces first successful outpatient application of Aquadex Smartflow
- Nuwellis Approves Stock Proposals at Special Meeting